L. Roy Papp & Associates LLP Buys 691 Shares of Procter & Gamble Company (The) $PG

L. Roy Papp & Associates LLP raised its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 65,028 shares of the company’s stock after purchasing an additional 691 shares during the period. Procter & Gamble accounts for approximately 1.2% of L. Roy Papp & Associates LLP’s portfolio, making the stock its 23rd largest holding. L. Roy Papp & Associates LLP’s holdings in Procter & Gamble were worth $10,360,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Brighton Jones LLC raised its stake in Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after acquiring an additional 13,617 shares during the period. Taylor Financial Group Inc. boosted its position in Procter & Gamble by 10.6% during the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after purchasing an additional 277 shares during the period. GAMMA Investing LLC increased its stake in shares of Procter & Gamble by 22.4% in the first quarter. GAMMA Investing LLC now owns 46,658 shares of the company’s stock worth $7,951,000 after purchasing an additional 8,537 shares in the last quarter. Compagnie Lombard Odier SCmA raised its position in shares of Procter & Gamble by 2.5% in the first quarter. Compagnie Lombard Odier SCmA now owns 1,166,917 shares of the company’s stock valued at $198,866,000 after purchasing an additional 28,605 shares during the period. Finally, Rockland Trust Co. lifted its stake in shares of Procter & Gamble by 6.4% during the 1st quarter. Rockland Trust Co. now owns 205,732 shares of the company’s stock valued at $35,061,000 after buying an additional 12,449 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Down 0.6%

PG opened at $149.69 on Friday. The stock’s fifty day moving average is $155.24 and its 200-day moving average is $159.53. Procter & Gamble Company has a one year low of $149.45 and a one year high of $180.43. The company has a market capitalization of $350.34 billion, a PE ratio of 22.99, a P/E/G ratio of 3.99 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period in the previous year, the business earned $1.40 earnings per share. Procter & Gamble’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on PG. Berenberg Bank lifted their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. UBS Group decreased their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday. Wells Fargo & Company cut their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. BNP Paribas reiterated an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, BNP Paribas Exane cut their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $172.21.

Insider Activity

In related news, CFO Andre Schulten sold 4,252 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the transaction, the chief financial officer directly owned 53,992 shares in the company, valued at $8,219,202.16. The trade was a 7.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jennifer L. Davis sold 3,227 shares of the business’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 in the last ninety days. 0.20% of the stock is owned by company insiders.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.